Quantinno Capital Management LP Trims Stock Position in Humana Inc. $HUM

Quantinno Capital Management LP trimmed its holdings in Humana Inc. (NYSE:HUM) by 61.1% during the 1st quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 29,585 shares of the insurance provider’s stock after selling 46,433 shares during the quarter. Quantinno Capital Management LP’s holdings in Humana were worth $5,130,000 at the end of the most recent reporting period.

A number of other institutional investors have also modified their holdings of HUM. Vanguard Group Inc. lifted its holdings in shares of Humana by 0.7% in the 4th quarter. Vanguard Group Inc. now owns 14,261,860 shares of the insurance provider’s stock valued at $3,652,890,000 after buying an additional 106,030 shares during the period. Capital International Investors raised its position in Humana by 113.9% during the fourth quarter. Capital International Investors now owns 5,818,008 shares of the insurance provider’s stock valued at $1,490,239,000 after acquiring an additional 3,097,571 shares in the last quarter. Pzena Investment Management LLC raised its position in Humana by 34.3% during the first quarter. Pzena Investment Management LLC now owns 5,470,982 shares of the insurance provider’s stock valued at $948,614,000 after acquiring an additional 1,398,774 shares in the last quarter. State Street Corp lifted its holdings in Humana by 1.8% in the fourth quarter. State Street Corp now owns 5,462,549 shares of the insurance provider’s stock valued at $1,403,877,000 after acquiring an additional 97,211 shares during the period. Finally, Massachusetts Financial Services Co. MA lifted its holdings in Humana by 28.9% in the fourth quarter. Massachusetts Financial Services Co. MA now owns 4,496,775 shares of the insurance provider’s stock valued at $1,151,759,000 after acquiring an additional 1,008,514 shares during the period. Hedge funds and other institutional investors own 92.38% of the company’s stock.

Analyst Ratings Changes

A number of equities research analysts have recently commented on the stock. Guggenheim raised their price objective on shares of Humana from $269.00 to $471.00 and gave the stock a “buy” rating in a research note on Thursday, July 30th. Barclays boosted their target price on shares of Humana from $344.00 to $407.00 and gave the company an “equal weight” rating in a research note on Friday, July 31st. Piper Sandler upgraded shares of Humana from a “hold” rating to an “overweight” rating and set a $463.00 price target on the stock in a research report on Thursday, July 30th. Deutsche Bank Aktiengesellschaft initiated coverage on shares of Humana in a report on Thursday, July 30th. They issued a “hold” rating for the company. Finally, Cantor Fitzgerald increased their target price on shares of Humana from $264.00 to $300.00 and gave the stock a “neutral” rating in a research note on Tuesday, July 7th. One investment analyst has rated the stock with a Strong Buy rating, fourteen have assigned a Buy rating, fourteen have assigned a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $391.87.

Humana Stock Up 1.1%

NYSE HUM opened at $367.98 on Friday. The company has a market cap of $44.19 billion, a P/E ratio of 34.81, a P/E/G ratio of 2.08 and a beta of 0.72. Humana Inc. has a one year low of $163.11 and a one year high of $428.88. The business has a fifty day moving average price of $375.61 and a 200 day moving average price of $270.85. The company has a debt-to-equity ratio of 0.62, a quick ratio of 1.74 and a current ratio of 1.74.

Humana (NYSE:HUM) last announced its quarterly earnings data on Wednesday, July 29th. The insurance provider reported $7.61 earnings per share (EPS) for the quarter, beating the consensus estimate of $7.27 by $0.34. The company had revenue of $40.89 billion during the quarter, compared to analysts’ expectations of $40.58 billion. Humana had a net margin of 0.88% and a return on equity of 11.20%. Humana’s revenue was up 26.2% compared to the same quarter last year. During the same quarter in the prior year, the company earned $6.27 EPS. Research analysts anticipate that Humana Inc. will post 9.08 EPS for the current fiscal year.

Humana Company Profile

Humana Inc (NYSE: HUM) is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana’s products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.

In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.